Blocking Platelet Aggregation Inhibits Thromboxane A 2 Formation by Low Dose Agonists But Does Not Inhibit Phosphorylation and Activation of Cytosolic Phospholipase A 2

By Carroll R.C.   Wang X.-f.   Lanza F.   Steiner B.   Kouns W.C.  

Thrombosis Research, Vol. 88, Iss. 2, 1997-10 ,pp. : 109-125

Elsevier

Access to resources Recommend Favorite

Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: Effect of inhibition of ADP and thromboxane A2 pathways

By Dawood Ban B.   Wilde Jonathan   Watson Steve P.  

Platelets, Vol. 18, Iss. 5, 2007-08 ,pp. : 329-345

Informa Healthcare

Access to resources Recommend Favorite

The role of thromboxane A 2 in increased whole blood platelet aggregation in oral contraceptive users

By Norris L.A.   Devitt M.   Bonnar J.  

Thrombosis Research, Vol. 81, Iss. 4, 1996-02 ,pp. : 407-417

Elsevier

Access to resources Recommend Favorite

Lipoprotein (a) reduces platelet aggregation apo(a)-mediated decreases in production via thromboxane A 2

By Barre D. E.  

Platelets, Vol. 9, Iss. 2, 1998-04 ,pp. : 93-96

Informa Healthcare

Access to resources Recommend Favorite

Habitual smoking causes an abnormality in platelet thromboxane A₂ metabolism and results in an altered susceptibility to aspirin effects

By Weber Artur-Aron   Liesener Sven   Schanz Andrea   Hohlfeld Thomas   Schror Karsten  

Platelets, Vol. 11, Iss. 3, 2000-05 ,pp. : 177-182

Informa Healthcare

Access to resources Recommend Favorite